eLifeDevelopmental BiologyPeer-reviewed journal article
Coordinated Tbx3/Tbx5 transcriptional control of the adult ventricular conduction system
Ozanna Burnicka-TurekiD, Katy Anne TrampeliD, Brigitte LaforestiD, Michael BromaniD, Xinan Holly YangiD, Zoheb KhaniD, Eric RytkiniD, Binjie LiiD, Ella Schaffer, Margaret GadekiD, Kaitlyn M SheniD, Igor R. EfimoviD, Ivan P. G. MoskowitziD
Abstract
The cardiac conduction system (CCS) orchestrates the electrical impulses that enable coordinated contraction of the cardiac chambers. The T-box transcription factors TBX3 and TBX5 are required for cardiac conduction system development and associated with overlapping and distinct human cardiac conduction system diseases. We evaluated the coordinated role of Tbx3 and Tbx5 in the murine ventricular conduction system (VCS). We engineered a compound Tbx3:Tbx5 conditional knockout allele for both genes located in cis on mouse chromosome 5. Conditional deletion of both T-box transcriptional factors in the ventricular conduction system, using the VCS-specific MinK:Cre, caused loss of VCS function and molecular identity. Combined Tbx3 and Tbx5 deficiency in the adult VCS led to conduction defects, including prolonged PR and QRS intervals and elevated susceptibility to ventricular tachycardia. These electrophysiological defects occurred prior to detectable alterations in cardiac contractility or histologic morphology, indicative of a primary conduction system defect. Tbx3:Tbx5 double knockout VCS cardiomyocytes revealed a transcriptional shift towards non-CCS-specialized working myocardium, indicating a change to their cellular identity. Furthermore, optical mapping revealed a loss of VCS-specific conduction system propagation. Collectively, these findings indicate that Tbx3 and Tbx5 coordinate to control VCS molecular fate and function, with implications for understanding cardiac conduction disorders in humans.
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TBX5 dosage governs ventricular cardiomyocyte maturation, specialization and dedifferentiation in vivo
Alexandra E. Giovou, Otto J. Mulleners, … Vincent M. Christoffels·bioRxiv·Apr 15, 2026
- Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease
Irfan S. Kathiriya, Kavitha S. Rao, … Benoit G. Bruneau·DevelopmentPeer-reviewed·Dec 16, 2025
- Conservation and divergence of transcriptional heterogeneity in the cardiac conduction system
Marwan Bakr, Saif Dababneh, … Kyoung-Han Kim·Journal of Molecular and Cellular CardiologyPeer-reviewed·Sep 28, 2026
- Deletion of Sphingosine 1-Phosphate Receptor 1 in cardiomyocytes during development leads to abnormal ventricular conduction and fibrosis
R. Jorgensen, M. Katta, … L. Wilsbacher·bioRxiv·Mar 15, 2020
- Integrated transcriptome and lineage analyses reveal novel catecholaminergic cardiomyocytes contributing to the cardiac conduction system in murine heart
T. Sun, A. Grassam-Rowe, … M. Lei·bioRxiv·Nov 4, 2022
- An atrial fibrillation-associated regulatory region modulates cardiac Tbx5 levels and arrhythmia susceptibility
Fernanda M. Bosada, Karel van Duijvenboden, … Vincent M. Christoffels·eLifePeer-reviewed·Jan 30, 2023